Project mission
PRO-MIND is a collaborative project involving companies, hospitals, and research centres working together to identify a natural therapeutic solution for patients suffering from gastrointestinal disorders, who frequently experience comorbid mental health conditions. In this context, the project explores the use of optimized probiotic formulations to simultaneously target gastrointestinal disorders and depressive symptoms by modulating the gut–brain axis. Through pre-clinical and clinical studies, PRO-MIND will assess the products’ efficacy, tolerability, and impact on the microbiota and on inflammatory processes. By restoring gut microbiota balance and influencing pathways linked to mood regulation, these improved probiotic-based interventions could represent a safer alternative or complement to conventional antidepressant therapies.
Project ID: ID 6107778 | CUP Code: E49I25001460007
